The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
Trials
15 November 2021
https://pubmed.ncbi.nlm.nih.gov/34781989/
Low-dose naltrexone (LDN)—review of therapeutic utilization
Med Sci (Basel)
21 September 2018
https://pubmed.ncbi.nlm.nih.gov/30248938/
Low-Dose Naltrexone Co-Treatment in the Prevention of Opioid-Induced Hyperalgesia (Abstract)
Cureus
02 September 2021
https://pubmed.ncbi.nlm.nih.gov/34646707/
Annalisa talks about Low Dose Naltrexone (LDN), Trigeminal Nerve pain and Lyme disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Annalisa shares her Low Dose Naltrexone (LDN), Trigeminal Nerve pain and Lyme disease story and how it help change her life.
LDN in Clinical Practice - Andrew McCall, MB, ChB, DFM (2021 Conference) (LDN, low dose naltrexone)
Use of LDN for Chronic Pain - Sahar Swidan, PHARM.D., ABAAHP, FAARFM, FACA (2021 Conference) (LDN, low dose naltrexone)
This talk is on the use of LDN for chronic pain. She reviews LDN’s actions in the CNS and the PNS, the immunomodulating effect of LDN, and some clinical trials on the use of LDN.
Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)
This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information.